{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:34:57Z","timestamp":1757540097680},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1016\/s0960-8966(98)00089-3","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T22:55:54Z","timestamp":1027637754000},"page":"38-40","source":"Crossref","is-referenced-by-count":13,"title":["IgM paraproteinemia in a patient with primary lateral sclerosis"],"prefix":"10.1016","volume":"9","author":[{"given":"Joy","family":"Desai","sequence":"first","affiliation":[]},{"given":"Michael","family":"Swash","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0960-8966(98)00089-3_BIB1","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archneur.1988.00520360022005","article-title":"Primary lateral sclerosis: a clinical diagnosis re-emerges","volume":"45","author":"Younger","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/S0960-8966(98)00089-3_BIB2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/115.2.495","article-title":"Primary lateral sclerosis: clinical features, neuropathology and diagnostic criteria","volume":"115","author":"Pringle","year":"1992","journal-title":"Brain"},{"key":"10.1016\/S0960-8966(98)00089-3_BIB3","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1212\/WNL.48.6.1671","article-title":"Lymphoproliferative disorders and motor neuron disease: an update","volume":"48","author":"Gordon","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/S0960-8966(98)00089-3_BIB4","first-page":"576","article-title":"Lymphoproliferative disorders and motor neuron disease","volume":"50","author":"Leone","year":"1998","journal-title":"To the editor. Neurology"},{"key":"10.1016\/S0960-8966(98)00089-3_BIB5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-2008-1041403","article-title":"Polyneuropathies associated with plasma cell dyscrasias","volume":"7","author":"Kelly","year":"1987","journal-title":"Semin Neurol"},{"key":"10.1016\/S0960-8966(98)00089-3_BIB6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1212\/WNL.44.3_Part_1.560","article-title":"Syndrome of continuous muscle fibre activity and plasmacytoma with IgM paraproteinemia","volume":"44","author":"Zifko","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/S0960-8966(98)00089-3_BIB7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1212\/WNL.45.4.827","article-title":"Autopsy-proven amyotrophic lateral sclerosis, Waldenstrom's macroglobulinemia and antibodies to sulphated glucuronic acid paragloboside","volume":"45","author":"Rowland","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/S0960-8966(98)00089-3_BIB8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1212\/WNL.40.4.595","article-title":"Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes","volume":"40","author":"Younger","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/S0960-8966(98)00089-3_BIB9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ana.410290114","article-title":"Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis","volume":"29","author":"Younger","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/S0960-8966(98)00089-3_BIB10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.0954-6820.1966.tb05453.x","article-title":"Frequency of pathological proteins (M-components) in 6,995 sera from an adult population","volume":"179","author":"Axelsson","year":"1966","journal-title":"Acta Med Scand"},{"key":"10.1016\/S0960-8966(98)00089-3_BIB11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/jnnp.33.3.338","article-title":"Central nervous system in motor neuron disease","volume":"33","author":"Brownell","year":"1970","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S0960-8966(98)00089-3_BIB12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/jnnp.64.6.809","article-title":"Ultrastructural characterisation of the M protein in nerve biopsy of patients with POEMS syndrome","volume":"64","author":"Adams","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S0960-8966(98)00089-3_BIB13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0161-5890(88)90074-0","article-title":"Activation of complement by human serum IgA, secretory IgA, and IgA1 fragments","volume":"25","author":"Hiemstra","year":"1988","journal-title":"Mol Immunol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896698000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896698000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T16:55:51Z","timestamp":1555606551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896698000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["S0960896698000893"],"URL":"https:\/\/doi.org\/10.1016\/s0960-8966(98)00089-3","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}